The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App in Bladder Cancer for Better Understanding of Symptoms, Quality of Life and Need for Supportive Care
The aims of this project are: * to develop and implement a national multimodality application for patients with bladder cancer that builds upon knowledge from the iBLAD study. * to investigate how the app, containing PRO questions on symptoms and QoL, information for health care providers, and peer-to-peer advice, can provide more knowledge on symptoms, QoL, and the need for supportive care. * to examine the usability of and patient satisfaction with the app using qualitative methods.
• Patients with bladder cancer defined as both urothelial tract-, bladder- and urethral cancer initiating first or second-line standard therapy with either chemotherapy or immunotherapy
• Age ≥ 18 years,
• Performance status ≤ 2
• Ability to read Danish
• No serious cognitive impairment
• Informed consent.